Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs)
Stephanie Wu, Marissa J. Carter, Windy Cole, Roselle Crombie, Daniel Kapp, Paul J. Kim, Catherine Milne, Joséph Molnár, Jeffrey Niezgoda, Kevin Woo, David D. Zabel, Rose L. Hamm, David Armstrong, Alan J Bock, Baljit Dheansa, Vickie R. Driver, Paul M. Glat, John C Lantis, Lydia Masako Ferreira, M. Mark Melin, Keyur Patel, Elia Ricci, Richard Simman, John S. Steinberg, William H Tettelbach, Dot Weir
Abstract
There are currently over 80 biomaterials derived from autologous, allogeneic, synthetic and xenogeneic sources, or a combination of any or all these types of materials, available for soft-tissue coverage to effect wound closure. Often generically referred to as cellular and/or tissue-based products (CTPs), they are manufactured under various trade names and marketed for a variety of indications.